Delivery Order SPE2DB24D2216-SPE2DB24FGMHT

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medical products. The contract has a ceiling value of $10,740.82 and runs through April 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The contract has a ceiling value of $5,512.13 and a completion date of February 20, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication, with a ceiling value of $2,652.56 and a performance period through May 17, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support federal healthcare programs. The award has a ceiling value of $4,221.32 and a completion date of March 12, 2025. This is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication, with a ceiling value of $2,040.72 and a period of performance through February 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,504.50 and a completion date of January 8, 2025. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $4,285.89 and a period of performance through January 28, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This award is a delivery order contract with a ceiling value of $2,836.98 made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription drug. The delivery order has a firm fixed price and an ultimate completion date of October 9, 2024. This contract is not a set-aside. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025. The contract has a ceiling value of $2,492.37 and covers the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a completion date of February 27, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a ceiling value of $10,346.72 and a completion date of April 30, 2024. The contract is a Firm Fixed Price (FFP) agreement and is not designated as a set-aside. AmerisourceBergen holds a significant...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB24FGMHT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a ceiling value of $6,925.50 and a performance period through July 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies in support of military treatment facilities, veterans' healthcare, and other federal government healthcare programs.

Generated 10/17/24, 9:13 AM